Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus amylovorus and Improved Intestinal Barrier Function

Research synthesisVery low evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported **beneficial** effects of *Lactobacillus amylovorus* on intestinal barrier function, with a **moderate** predominant effect size. The limited evidence (2 statistically significant findings) suggests improvements in tight junction gene expression, villus height, and mucosal immune markers, primarily in neonatal or gestating pig models. No clear dose or population segment could be identified due to incomplete reporting.

Caveats: Only 3 studies available, all in animal models (piglets, sows, lambs) — human evidence absent. Two of the three papers are from 2026 and appear to be future/placeholder entries, limiting credibility. Doses, forms, and study durations were not reported in the database. One paper's intervention was a different substance (EGC), not *L. amylovorus*, so the link to the supplement is indirect.

Generated May 11, 2026
5 of 5 papers
Back to top